Tiazofurin (2-8-D-ribofuranosylthiazole4-carboxamide) and selenazofurin (2-%-D-ribofuranosylselenazole4-crboxmiude) are synthetic 'C" nucleosides whose antineoplastic activity depends on their conversion to tiazofurin-adenine dinucleotide and selenazofurin-adenine dinucleotide which are analogs of NAD. The present study was conducted to determine whether these nucleoside analogs and their dinucleotide derivatives interfere with NAD metabolism and in particular with the NADdependent enzyme, poly(ADP-ribose) polymerase. Incubation of L1210 cells with 10 gM tiazofurin or selenazofurin resulted in inhibition of cell growth, reduction of cellular NAD content, and interference with NAD synthesis. Using 114Clnicotinamide to study the uptake of nicotinamide and its conversion to NAD, we showed that the analogs interfere with NAD synthesis, apparently by blocking formation of nicotinamide mononucleotide. The analogs also serve as weak inhibitors of poly(ADPribose) polymernse, which is an NAD-utilizing, chromatinbound enzyme, whose function is required for normal DNA repair processes. Continuous incubation of L1210 cells in tiazofurin or selenazofurin resulted in progressive and synergistic potentiation of the cytotoxic effects of DNA-damaging agents, such as 1,3-bis(2-chloroethyl)-1-nitrosourea or N-methyl-N'-nitro-N-nitrosoguanidine. These studies provide a basis for designing chemotherapy combinations in which tiazofurin or selenazofurin are used to modulate NAD and poly(ADP-ribose) metabolism to synergistically potentiate the effects of DNA strand-disrupting agents.
Introduction
Tiazofurin (Taz)' (2-f3-D-ribofuranosylthiazole-4-carboxamide) and selenazofurin (Sel) (2-f3-D-ribofuranosylselenazole-4-carReceivedfor publication 7 August 1984 and in revisedform 25 October 1984. 1. Abbreviations used in this paper: 3-AB, 3-aminobenzamide; ADPribose, adenosine diphospho-ribose; BCNU, 1,3-bis(2-chloroethyl)-1-nitrosourea; DMS, dimethylsulfate; GMP, guanosine 5'-monophosphate; IMP, inosine 5'-monophosphate; MNNG, N-methyl-N'-nitro-N-nitrosoguanidine; NMN, nicotinamide mononucleotide; SAD, selenazofurinadenine dinucleotide; Sel, selenazofurin; TAD, tiazofurin-adenine dinucleotide; Taz, tiazofurin. boxamide) are synthetic "C" nucleoside analogs with potent antineoplastic activity in experimental murine and human tumors (1) (2) (3) (4) (5) . They are highly effective in treating a variety of murine tumors including L1210 leukemia, P388 leukemia, and the highly resistant Lewis lung carcinoma (1) (2) (3) (4) . They are also effective in vitro against several human tumors including the human colon adenocarcinoma line LoVo/L and the human promyelocytic leukemia cell line HL-60 (6, 7) . Sel also induces maturation in HL-60 cells (7) . Using human tumor-cloning assays to examine cells from a variety of solid tumors, Taz was found to have significant antitumor effects in -17% of cases (8) and this agent is now undergoing phase I and II clinical trials (9-1 1).
The antitumor effects of Taz and Sel are mediated, in part, by their conversion to tiazofurin-adenine dinucleotide (TAD) and selenazofurin-adenine dinucleotide (SAD), which are analogs of NAD (4, 12) . TAD and SAD are synthesized by nicotinamide mononucleotide ATP *adenylyl transferase; they inhibit the NAD-dependent enzyme, inosine 5'-monophosphate (IMP) dehydrogenase, which converts IMP to guanosine 5'-monophosphate (GMP). As a result of this inhibition, cells become depleted of GMP and they accumulate the precursor IMP (4, 12, 13) . GMP depletion appears to be part of their cytotoxic mechanism since the effect of these compounds can be overcome by supplying cells with guanosine nucleosides (4) . The importance of converting these analogs to their dinucleotide derivatives is demonstrated by the fact that a line of P388 cells found to be deficient in its ability to convert Taz to TAD is resistant to the acute toxic effects of Taz (14) . Furthermore, sensitivity of murine tumors to the pharmacologic effects of Taz correlates with their intracellular levels of TAD (15) .
Since Taz and Sel are metabolized to NAD analogs by enzymes normally involved in NAD synthesis and since the dinucleotide analogs interfere with NAD-dependent enzymes such as IMP dehydrogenase, it seemed possible that the nucleoside analogs and/or their metabolites might interfere with some other aspects of NAD metabolism and in particular with the NAD-dependent enzyme, poly(ADP-ribose) polymerase. Because of the important requirement for NAD and poly(ADP-ribose) metabolism in the DNA repair process (16- (20, 21) .
Alkaline elution studies were used to evaluate DNA strand breaks (22, 23 determined by treating the filters with 0.4 ml 1 N HCl at 70'C for 1 h followed by 2.5 ml 0.4 N NaOH at room temperature for 30 min and then the addition of 10 ml Scintiverse. Radioactivity remaining in the tubing was recovered by five washes with 3 ml 0.4 N NaOH and counted in Scintiverse as above. Data is plotted'as the radioactive DNA remaining on the filters as a function of time of elution (22, 23) . For irradiation experiments, cells were collected by centrifugation, resuspende4 in cold PBS at a concentration of 5 X 105/ml, and irradiated in an icewater bath using a Gamma Cell 5,000 (Atomic Energy Canada Ltd., Ontario, Canada) at an incident dose of 850 rads/min. Following irradiation, cells were applied directly to filters, lysed, and eluted as above.
The effect of inhibitors on poly(ADP-ribose) polymerase was evaluated with enzyme purified from lamb thymus (24) . Reaction systems Sel significantly reduced the growth rate and 10 AM Sel completely inhibited it. These effects are undoubtedly mediated, in part, by inhibition of IMP dehydrogenase resulting in depletion of guanine nucleotides and consequent inhibition of DNA, RNA synthesis, and cell growth (12) (13) (14) . Fig. 1 While the control L12 10 cells showed a decrease in NAD' content per cell, the accompanying increase in cell numbers actually resulted in a net increase of NAD' in the culture system. This is shown in accumulation, and therefore, the highest ratio of nicotinamide to NAD. Thus, prolonged exposure to Taz or Sel progressively interferes with the cell's ability to utilize nicotinamide for the synthesis of NAD contributing to the decreased cellular NAD pools and increased accumulation of the precursor nicotinamide.
To further identify the location of the Taz-and Sel-induced block in NAD synthesis, we examined the intermediates on the pathway between nicotinamide and NAD. Table I shows the distribution of these intermediates in control cells and in cells pretreated with 10 MM Taz or 10 MM Sel. The decreased incorporation into NAD is associated with a relatively constant level of labeling of NADP as a percent of NAD, indicating that there is a decrease in synthesis of all pyridine nucleotides and not merely a shift from NAD to NADP pools. Under these conditions of decreased pyridine nucleotide synthesis, there is a relative increase in labeling of nicotinamide pools with no significant increase in NMN. Thus the block appears to be at the level of nicotinamide phosphoribosyl transferase, the enzyme responsible for converting nicotinamide to NMN. It is interesting to note that the cells do not shift much of the intracellular nicotinamide into the alternate pathways of synthesizing nicotinic acid or 1-methyl nicotinamide (20, 21, 28) .
Effects of inhibitors on poly(ADP-ribose) polymerase. Since Taz and Sel are metabolized into the NAD analogs, TAD and SAD, we examined each of these compounds for their effect on poly(ADP-ribose) polymerase. Fig. 3 compares the effects of these agents on the activity of purified poly(ADP-ribose) polymerase in the presence of two different substrate concenUptakes in control cells were performed at each time point and were essentially the same as the point indicated in each figure at 0 time. Treated cells were incubated in media supplemented with 1 AM Sel (n), 10 AM Sel (i), 1 (24) . In the presence of 450 ,MM NAD, Taz and Sel were weak inhibitors producing only 10 and 20% inhibition at inhibitor concentrations of 5 mM. 5 mM TAD was significantly more effective, producing 70% inhibition. SAD produced a similar inhibition curve at lower concentrations but was not tested at 5 mM due to problems (16) (17) (18) . Cells with restricted activity of poly(ADP-ribose) polymerase due to low NAD levels or the presence of enzyme inhibitors are deficient in their ability to repair DNA strand breaks (16) (17) (18) . To determine whether the Ekution Fraction Figure 4 . Alkaline elution studies were performed with cells containing ['4Clthymidine-labeled DNA as described in Methods. The curves for control cells (o) were the same at the beginning and end of the experiment. In A, cells were incubated with I uM Taz for 24 h (A) or metabolic effects of Taz and/or Sel were associated with the development of DNA strand breaks, we incubated cells with these analogs and analyzed DNA integrity by alkaline elution after 6, 24, and 48 h of incubation. Fig. 4 shows that continuous incubation of L1210 cells with Taz and Sel for 24 and 48 h resulted in dose-dependent increases in DNA strand breaks. No significant DNA strand breaks occurred when cells were incubated with these compounds for only 6 h. By comparing the curves produced in the presence of the inhibitors to those produced by graded doses of y-irradiation (Fig. 4 C) , it is apparent that incubation in 10 ,gM Taz or Sel produced strand break curves that fell between those produced by 75 and 150 rad. The breaks which occur in the presence of Taz or Sel may be spontaneous breaks which fail to be repaired because of the presence of these agents. While the radiation-induced breaks are usually rapidly repaired (29) , those produced by incubation of cells with Taz or Sel appear to be more persistent and therefore potentially more toxic. Poly(ADP-ribose) synthesis is required for the repair of DNA damage induced by agents such as MNNG or BCNU (16) (17) (18) . Since Taz and Sel can interfere with poly(ADPribose) synthesis by lowering levels of the substrate NAD and by direct inhibition of the enzyme, it seemed possible that these agents would potentiate the cytotoxic effects of MNNG and BCNU. To evaluate this possibility, L1210 cells were continuously treated with Taz and Sel for 48 h. At the beginning of the experiment and again after 24 and 48 h, separate groups of cells were treated with 5 Mg/ml MNNG or 100 MM BCNU. For each group, cell viability was determined by trypan blue analysis 6 h after treatment with the various combinations of agents. Fig. 5 shows that as cells are incubated in Taz or Sel they become progressively more susceptible to the cytocidal effects of MNNG and BCNU. Fig. 5 A shows that the control cells were 98% viable at the beginning and they retained their high level of viability throughout the experiment. At the beginning of the experiment, treatment of the control cells with 5 pg/ml MNNG or 100 ,uM BCNU reduced their viability to 81 and 88%, respectively. When cells were maintained in control growth medium for 24 or 48 h and then treated with MNNG or BCNU, the decrease in viability was approximately the same as it was at the beginning of the experiment and the viability in all cases remained >80%.
Preincubation of cells with Taz or Sel for 24or 48 h resulted in a marked increase in their susceptibility to MNNG or BCNU. Fig. 5 B shows that after 24 h in 10 MM Taz, viability was 92%, and after 48 h, it was reduced to 64%. Addition of MNNG after 24-h preincubation with 10 MM Taz resulted in a decrease in viability to 55%. Similarly, there were marked decreases in viability when MNNG or BCNU were added to cells which had been preincubated with 10 MtM Taz for 48 h. The decrease in viability that occurred when BCNU or MNNG were added to cells that were preincubated in Taz was much greater than that which occurred when the same agents were added to control cells. This suggests a synergistic interaction between preincubation with Taz and treatment with BCNU or MNNG. Hours Fig. 5 C shows that incubation in 10 MM Sel had the greatest, single agent effect in reducing cell viability, with 70% viability after 24 h and 38% after 48 h. The cytocidal effects of MNNG or BCNU were potentiated by pretreatment with Sel in a manner similar to the potentiation by Taz. Thus, while MNNG or BCNU did not significantly affect viability of control cells, their cytotoxic effects were significantly potentiated by 48-h preincubation with 10 MM Taz or Sel. At I MM, Taz and Sel were not as effective as they were at 10 MM in potentiating the effects of BCNU and MNNG.
Discussion
Taz and Sel are promising new antitumor agents (6) (7) (8) (9) . Understanding their mechanism of action and metabolic effects should provide an important basis for developing strategies for their optimal use in single agent and combination chemotherapy protocols. The acute effects of these agents appear to be mediated by their conversion to analogs of NAD which subsequently interfere with IMP dehydrogenase, resulting in the depletion of guanine nucleotides and the consequent inhibition of DNA, RNA synthesis, and cell growth (4, (12) (13) (14) . Our studies indicate that on a chronic basis, treatment with Taz or Sel also interferes with several aspects of pyridine nucleotide and poly(ADP-ribose) metabolism. Thus Taz, Sel, and their metabolites interfere with NAD synthesis and also interfere with activity of poly(ADP-ribose) polymerase. Their effects on NAD synthesis appear to be at the level of nicotinamide phosphoribosyl transferase. This enzyme is known to be inhibited by NAD (30) , and thus, it is possible that the dinucleotide derivatives, TAD and SAD, function as NAD analogs in this system and inhibit conversion of nicotinamide to NMN. Our preliminary studies, using a new cycling assay to measure nicotinamide phosphoribosyl transferase, indicate that the enzyme is inhibited by TAD. Taz, Sel, and their metabolites also presumably function as competitive inhibitors of poly(ADP-ribose) polymerase since they are more effective inhibitors at low concentrations of NAD. Our studies suggest (24, 32) . Subsequent ADP-ribose residues are then added by O-glycosidic linkages to form homopolymers which have been found to occur in excess of 100 residues. Poly(ADP-ribosylation) in response to DNA damage has been shown to alter chromatin structure and to affect the activity of several enzymes including the polymerase itself, DNA ligase, topoisomerase, and a Ca", Mg"+-dependent endonuclease (32) (33) (34) (35) . Thus, poly(ADP-ribosylation) may affect the DNA repair process by altering chromatin structure and also by affecting the activities of the enzymes involved in this process.
Treatment of cells with inhibitors of poly(ADP-ribose) polymerase can be used to potentiate the cytotoxicity of DNAdamaging agents. For example, 3-AB potentiates the toxic effects of treating cells with the alkylating agent dimethyl sulfate (DMS). Similar treatment with 3-amino benzoic acid (a noninhibitory analog) has no effect on the toxicity of DMS (16, 36) . At the molecular level, the inhibition of poly(ADPribose) synthesis has been shown to prevent the resealing of DNA strand breaks (16, 37) .
Poly(ADP-ribose) polymerase has recently been shown to be a potential target for cancer chemotherapy, especially in protocols where enzyme inhibitors can be combined with agents whose primary mechanism of action is mediated by their ability to produce DNA strand disruptions. For example, the poly(ADP-ribose) polymerase inhibitor, 6-aminonicotinamide, has been shown to potentiate the antitumor effects of BCNU against L1210 leukemia in vivo and in vitro (38) . Another poly(ADP-ribose) polymerase inhibitor, 3-AB, has been shown to potentiate the antitumor effect of bleomycin in mice bearing the Ehrlich ascites carcinoma (39). As compared with 3-AB, Taz, Sel, and their intracellular metabolites were found to be weak to moderate inhibitors of poly(ADP-ribose) polymerase. However, their ability to interfere with NAD synthesis produces a reduction in cellular NAD pools, which enhances their ability to act as competitive inhibitors of poly(ADP-ribose) polymerase. This inhibition was associated with the development and persistence of DNA strand breaks and also sensitized the cells to the cytotoxic effects of BCNU or MNNG. These experiments show that continuous exposure to Taz or Sel results in increasing sensitization to MNNG or BCNU. This sensitization is probably further enhanced by the effects of these compounds on guanine nucleotide pools due to inhibition of IMP dehydrogenase (12) (13) (14) (15) . It is also probable that these agents affect other metabolic processes by interfering with pyridine nucleotide-dependent dehydrogenases. In addition, we have previously shown that the depletion of pyridine nucleotide levels leads to an inability of cells to maintain ATP pools and energy-dependent functions (40 (9) .
The studies outlined above provide a basis for developing synergistic chemotherapy combinations using Taz and/or Sel plus DNA strand-disrupting agents. The possibility needs to be examined that even more effective regimens can be developed by using DNA strand-disrupting agents in combination with these nucleoside analogs to modulate NAD synthesis along with nicotinamide analogs that inhibit poly(ADP-ribose) synthesis to provide sequential blockades of this pathway.
